Inflation Reduction Act policies need fixing, not celebrating

Published



This week, the Biden Administration released the first ten medicines that will be subject to price negotiation. These negotiations are possible thanks to the key components in the Inflation Reduction Act (IRA) that was passed last year. While it’s easy to think that this will save money, the hard fact is that it probably will not save patients money at all and will actually hurt the drugs that are in development. That is why when the drug list was announced, we saw headlines like “A Tragic Day For American Patients” and “Today is Not A Day To Celebrate”

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.